Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor.
J B Imboden, G Pattison
J B Imboden, G Pattison
Published May 1, 1987
Citation Information: J Clin Invest. 1987;79(5):1538-1541. https://doi.org/10.1172/JCI112986.
View: Text | PDF
Research Article

Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor.

  • Text
  • PDF
Abstract

Inositol 1,4,5-trisphosphate (Ins-1,4,5-P3), a Ca2+-mobilizing messenger, can be phosphorylated by a cytoplasmic kinase, yielding inositol 1,3,4,5-tetrakisphosphate (Ins-1,3,4,5-P3). We observed that stimulation of the antigen receptor on a malignant human T cell line, Jurkat, led to substantial, sustained increases in Ins-1,4,5-P3 and InsP4. The Ins-1,4,5-P3 kinase partially purified from resting Jurkat cells had a maximum velocity (Vmax) of 0.09 nmol/min/mg protein and an apparent Michaelis constant (Km) of 0.2 microM. When the kinase was partially purified 10 min after stimulation of the antigen receptor or after the addition of phorbol myristate acetate, the Vmax was increased twofold. The activity of the Ins-1,4,5-P3 kinase obtained from either resting or stimulated Jurkat cells was enhanced in vitro by increasing the concentration of free Ca2+ from 0.1 to 0.5 microM. These results indicate that the activity of the Ins-1,4,5-P3 kinase is regulated as a consequence of stimulating the T cell antigen receptor.

Authors

J B Imboden, G Pattison

×

Loading citation information...
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts